Avoiding the Premature Introduction of Psychedelic Medicines in Alzheimer’s Disease and Related Disorders

, , , &
American Journal of Bioethics Neuroscience 14 (2):129-131 (2023)
  Copy   BIBTEX

Abstract

Peterson et al. (2023) identify two potential uses of psychedelic drugs in Alzheimer’s disease and related disorders (AD/ADRD). The first is to treat depression and anxiety that commonly occur afte...

Categories

Keywords

Reprint years

DOI

10.1080/21507740.2023.2188287

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,960

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Psychedelic Research for Dementia Risks Perpetuating Structural Failures and Inadequacies in Aged Care.Hojjat Soofi & Cynthia Forlini - 2023 - American Journal of Bioethics Neuroscience 14 (2):131-134.
Publishing the Biotechnical Futures of Alzheimer’s Disease.James Rupert Fletcher - 2023 - American Journal of Bioethics Neuroscience 14 (2):124-126.
Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related Dementias.Andrew Peterson, Emily A. Largent, Holly Fernandez Lynch, Jason Karlawish & Dominic Sisti - 2023 - American Journal of Bioethics Neuroscience 14 (2):107-123.
Journey to Narayama: Cultural Complexities, Psychedelics and Dementia.Reina Ozeki-Hayashi & Dominic J. C. Wilkinson - 2023 - American Journal of Bioethics Neuroscience 14 (2):145-147.
Barriers and Facilitators to the Equitable Access of Psychedelic Medical Care and Research in Alzheimer’s Disease and Related Dementias.Kaila A. Rudolph - 2023 - American Journal of Bioethics Neuroscience 14 (2):136-138.
Ethical Considerations at the Intersection Between Psychedelic-Assisted Psychotherapy and Medical Assistance in Dying.Daniel Rosenbaum, Matthew Cho, Evan Schneider, Sarah Hales & Daniel Z. Buchman - 2023 - American Journal of Bioethics Neuroscience 14 (2):139-141.
Toward a Broader Psychedelic Bioethics.Edward Jacobs, David Bryce Yaden & Brian D. Earp - 2023 - American Journal of Bioethics Neuroscience 14 (2):126-129.
Alzheimer's Disease and Related Disorders. Etiology, Pathogenesis, and Therapeutics.H. T. Wright - 2000 - Bioessays 22 (7):682-683.
The Accelerated Approval of Aducanumab Invites a Rethink of the Current Model of Drug Development for Alzheimer's Disease.Timothy Daly & Stéphane Epelbaum - 2023 - American Journal of Bioethics Neuroscience 14 (3):332-335.
Is There a Right to Psychedelic-Assisted Therapy?Zak A. Kopeikin - 2025 - American Journal of Bioethics 25 (1):80-83.

Analytics

Added to PP
2023-04-27

Downloads
27 (#840,386)

6 months
7 (#764,599)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Adrian Carter
Monash University
Wayne Hall
State University of New York (SUNY)
John Gardner
James Madison University

Citations of this work

No citations found.

Add more citations

References found in this work

Add more references